JUST-IN:New COVID-19 Variant XEC in 29 Countries---FG creates awareness.

The XEC variant, already confirmed in 29 countries

JUST-IN:New COVID-19 Variant XEC in 29 Countries---FG creates awareness.

The Federal Government has issued a directive to chief medical directors and medical directors of tertiary hospitals, urging them to activate heightened alert systems for detecting COVID-like symptoms amid concerns over the newly identified XEC COVID-19 variant.

The XEC variant, already confirmed in 29 countries, has demonstrated a significant growth advantage over other circulating strains, raising public health concerns.

In a circular dated December 5, 2024, with reference number DHS/INSPDIV/017/VOL.1/46, Dr. O. N. Anuma, Head of the Teaching Hospital Division for the Permanent Secretary, emphasized the need for immediate vigilance.

The letter, titled “Letter of Conveyance in Respect of the Newly Detected XEC COVID-19 Strain,” highlighted the variant’s rapid spread, first reported in Australia, and called for proactive measures to mitigate its potential impact.

The circular read in part: “I am directed to inform you of a newly detected XEC COVID-19 variant, which has been reported in Australia and has already spread to 29 countries globally. 

This variant has shown a growth advantage over other circulating strains, raising concerns about its potential impact on public health.” 

Hospitals have been advised to activate alert systems for identifying and managing patients with COVID-like symptoms promptly.

Additionally, the government urged collaboration among relevant committees and stakeholders to enhance data sharing and implement robust monitoring protocols.

Timely communication with the Federal Ministry of Health is deemed crucial for effective response strategies.

The letter concluded with a note of encouragement: “Please accept, as always, the assurances of the permanent secretary’s warm regards.”

This proactive stance underscores the government’s commitment to safeguarding public health as the world grapples with emerging COVID-19 variants.